Sign In

Communications of the ACM

ACM Careers

Promising Gene Therapies Pose Million-Dollar Conundrum

View as: Print Mobile App Share:
Sickle cell anemia

People with sickle cell anaemia are among those targeted by a slew of new gene therapies.

Credit: Kim Hairston/Baltimore Sun/MCT/Getty

Drugs that act by modifying a patient’s genes are close to approval in the United States, and one is already available in Europe. The developments mark a triumph for the field of gene therapy, once considered controversial.

From Nature
View Full Article



No entries found